---
schema_version: "secwatch.filing_event.v1"
accession: "0001100682-21-000028"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2021-12-27T23:59:59+00:00"
generated_at: "2026-06-27T22:15:27.772290+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CRL grants $5M long-term equity award to EVP LaPlume with 5-year cliff vesting and rTSR PSUs

## Summary
- Joseph W. LaPlume receives $5M total fair value: 50% RSUs (6,771 units) cliff vesting Dec 25, 2026.
- 50% in PSUs (5,096 target) based on 5-year relative TSR vs S&P Healthcare 500, payout 0%-200%.
- Grant effective Dec 25, 2021; recognizes LaPlume's contributions and critical role in strategic growth.

## SEC filing metadata
- accession: 0001100682-21-000028
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2021-12-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000110068221000028/0001100682-21-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000110068221000028/crl-20211222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001100682-21-000028
- JSON: https://secwatch.observer/filing/0001100682-21-000028.json
- Plain text: https://secwatch.observer/filing/0001100682-21-000028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.